- Home
- COEP vs FLYX Comparison
COEP vs FLYX Comparison
Compare COEP & FLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- FLYX
- Stock Information
- Founded
- COEP 2017
- FLYX 2015
- Country
- COEP United States
- FLYX United States
- Employees
- COEP N/A
- FLYX N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- FLYX Blank Checks
- Sector
- COEP Health Care
- FLYX Finance
- Exchange
- COEP Nasdaq
- FLYX Nasdaq
- Market Cap
- COEP 72.1M
- FLYX 79.8M
- IPO Year
- COEP N/A
- FLYX N/A
- Fundamental
- Price
- COEP $14.79
- FLYX $3.88
- Analyst Decision
- COEP
- FLYX
- Analyst Count
- COEP 0
- FLYX 0
- Target Price
- COEP N/A
- FLYX N/A
- AVG Volume (30 Days)
- COEP 34.6K
- FLYX 16.1K
- Earning Date
- COEP 11-10-2025
- FLYX 11-13-2025
- Dividend Yield
- COEP N/A
- FLYX N/A
- EPS Growth
- COEP N/A
- FLYX N/A
- EPS
- COEP N/A
- FLYX N/A
- Revenue
- COEP $263,555.00
- FLYX $347,746,000.00
- Revenue This Year
- COEP N/A
- FLYX $28.47
- Revenue Next Year
- COEP N/A
- FLYX $22.44
- P/E Ratio
- COEP N/A
- FLYX N/A
- Revenue Growth
- COEP N/A
- FLYX 17.09
- 52 Week Low
- COEP $2.31
- FLYX $1.90
- 52 Week High
- COEP $19.19
- FLYX $6.90
- Technical
- Relative Strength Index (RSI)
- COEP 46.31
- FLYX 48.38
- Support Level
- COEP $14.50
- FLYX $3.51
- Resistance Level
- COEP $15.49
- FLYX $3.97
- Average True Range (ATR)
- COEP 0.73
- FLYX 0.29
- MACD
- COEP -0.10
- FLYX 0.00
- Stochastic Oscillator
- COEP 14.91
- FLYX 47.50
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.